Capsovision (CV) Stock Performance
- Closing price (02:49 PM Central Europe, Thursday 22nd): USD 6.8
- Price change (last 24 h): +1.8 %
- Volume (last 24 h): USD 1.2 million
- Shares outstanding: 53.2 million
- Market capitalization: USD 361.8 million
- 7‑month trend: +7.94 % since the end of last month
- 200‑day simple moving average: USD 6.34
- 52‑week high: USD 15.37 (recorded 12/11/2025)
- 52‑week low: USD 4.50 (recorded 02/20/2026)
Comparative Performance of Related Stocks (Last 24 h)
| Ticker | Current price | Price change | Market cap (USD) |
|---|---|---|---|
| BMRC (Bank Of Marin /Ca) | USD 26.64 | –1.08 % | 429.1 million |
| TECX (Tectonic Therapeutic) | USD 21.84 | +0.05 % | 426.7 million |
| EIKN (Eikon Therapeutics) | USD 8.00 | –2.20 % | 433.3 million |
| SPRY (Ars) | USD 4.18 | –2.56 % | 426.6 million |
| SENS (Senseonics) | USD 7.97 | –2.92 % | 434.1 million |
Summary
Capsovision experienced a modest rise of 1.8 % in the most recent 24‑hour period, trading at USD 6.8 per share. The stock’s market capitalization remains at USD 361.8 million, with a 7‑month upward trend of 7.94 %. Comparative analysis shows mixed movement among related healthcare and technology stocks, with most experiencing slight declines, except for a marginal increase in Tectonic Therapeutic.
